Objective: To review the experience of the Immunodeficiency Clinic of the Department of Infectious Diseases at Hospital Infantile de México "Federico Gómez", in the management of children with HIV infection and AIDS.

Material And Methods: the medical records of 130 patients with a clinical and laboratory diagnosis of HIV/AIDS seen between September 1985 and June 1994 were reviewed. Data was obtained regarding diagnosis, epidemiological risk factors, clinical features, types and numbers of bacterial and opportunistic infections, malignancies, hospitalizations, general and specific treatment and outcome. The diagnosis followed CDC guidelines and was established in all 130 patients serologically with ELISA and Western Blot. In infants < 18 months, diagnosis was made by detection of p24 and/or viral culture in two separate occasions.

Results: Data from 130 subjects was obtained; 74 were male and 56 female for a M:F ratio of 1.3:1. With regards to mode of transmission, 62.3% was vertical, 20.8% post transfusion, 8.5% hemophiliacs (the latter two males were cases before occurred 1987), 6.2% sexual and 2.2% unknown. With regards to additional risk factors, in 35 cases the parents were heterosexual, in 18 one parent had a history of transfusion, and in eight the father was bisexual. According to the CDC classification; 16 had indeterminate infection or PO; nine were asymptomatic or P1; and 105 were symptomatic or P2. Eighty two patients had nonspecific findings, 60 had neurologic manifestations, 18 had lymphocytic interstitial pneumonia and four had secondary malignancies. It was possible to document 296 episodes of secondary infections: 154 bacterial, 58 opportunistic, and 84 with other pathogens.

Conclusions: in Mexico, as in other Western countries, vertical transmission has become the dominant form of acquiring HIV infection in children, reflecting a change in the epidemiology of infection in women of child bearing age. Moreover, since IV drug use is a very limited phenomenon in Mexico, heterosexual transmission is the major form of transmission in women.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hiv infection
8
130 patients
8
risk factors
8
bacterial opportunistic
8
[hiv infection
4
infection mexican
4
mexican children]
4
children] objective
4
objective review
4
review experience
4

Similar Publications

Background: Cognitive function decline is a problem in aging people living with HIV (PLWHIV). COVID-19 infection is associated with neuropsychiatric manifestations that may persist. The aim of our study was to evaluate cognitive function in PLWHIV before and after COVID-19 infection.

View Article and Find Full Text PDF

Background: HIV and tuberculosis (TB) co-infection poses a significant health challenge, particularly when involving the central nervous system (CNS), where it leads to severe morbidity and mortality. Current treatments face challenges such as drug resistance, immune reconstitution inflammatory syndrome (IRIS), and persistent inflammation. Glutathione (GSH) has the therapeutic potential to enhance treatment outcomes by improving antibiotic efficacy, reducing inflammation, and mitigating immune dysfunction.

View Article and Find Full Text PDF

Second-generation integrase strand transfer inhibitors (INSTIs) are strongly recommended for people living with HIV-1 (PLWH). The emergence of resistance to second-generation INSTIs has been infrequent and has not yet been a major issue in high-income countries. However, the delayed rollouts of these INSTIs in low- to middle-income countries during the COVID-19 pandemic combined with increased transmission of drug-resistant mutants worldwide are leading to an increase in INSTI resistance.

View Article and Find Full Text PDF

Anogenital inflammation is a critical risk factor for HIV acquisition. The primary preventative HIV intervention, pre-exposure prophylaxis (PrEP), is ineffective in blocking transmission in anogenital inflammation. Pre-existing sexually transmitted diseases (STIs) and anogenital microbiota dysbiosis are the leading causes of inflammation, where inflammation is extensive and often asymptomatic and undiagnosed.

View Article and Find Full Text PDF

Background: Severe COVID-19 presents a variety of clinical manifestations associated with inflammatory profiles. People living with HIV (PLWH) could face a higher risk of hospitalization and mortality from COVID-19, depending on their immunosuppression levels. This study describes inflammatory markers in COVID-19 clinical outcomes with and without HIV infection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!